INTERNATIONAL PATENT: REGENXBIO INC. FILES APPLICATION FOR "METHODS AND FORMULATIONS FOR TREATING MUCOPOLYSACCHARIDOSIS II-ASSOCIATED HEARING LOSS WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE"

GENEVA, April 16 -- REGENXBIO INC. (9804 Medical Center DriveRockville, MD 20850) filed a patent application (PCT/US2024/049410) for "METHODS AND FORMULATIONS FOR TREATING MUCOPOLYSACCHARIDOSIS II-ASSOCIATED HEARING LOSS WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE" on Oct 01, 2024. With publication no. WO/2025/075963, the details related to the patent application was published on Apr 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOULOS, Nidal (c/o Regenxbio Inc.9804 Medical Center DriveRockville, MD 20850), PHILLIPS, Dawn (c/o Regenxbio Inc.9804 Medical Center DriveRockville, MD 20850...